CYP2C8/9/18/19 Polyclonal Antibody

CYP2C18 encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. Cytochrome P450 2C8/9/18/19 localizes to the endoplasmic reticulum but its specific substrate has not yet been determined. CYP2C18 is located within a cluster of cytochrome P450 genes on chromosome 10q24. An additional gene, CYP2C17, was once thought to exist; however, CYP2C17 is now considered an artefact based on a chimera of CYP2C18 and CYP2C19. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Introducing the CYP2C8/9/18/19 Polyclonal Antibody, a cutting-edge scientific tool designed to facilitate accurate and reliable research in the field of drug metabolism. This high-quality antibody is meticulously developed using advanced techniques to ensure exceptional specificity and sensitivity, enabling precise detection and quantification of the cytochrome P450 enzymes CYP2C8, CYP2C9, CYP2C18, and CYP2C19.

The CYP2C8/9/18/19 Polyclonal Antibody boasts a comprehensive polyclonal nature, allowing for broad recognition of multiple epitopes across the target enzymes. This feature enhances the antibody's versatility, making it an ideal choice for various applications, including immunohistochemistry, western blotting, and enzyme-linked immunosorbent assays (ELISA).

With its exceptional performance characteristics, this antibody exhibits minimal cross-reactivity with other cytochrome P450 enzymes, ensuring accurate and specific results. Its high affinity and sensitivity enable researchers to detect even low expression levels of CYP2C8, CYP2C9, CYP2C18, and CYP2C19, facilitating in-depth investigations into their roles in drug metabolism and personalized medicine.

The CYP2C8/9/18/19 Polyclonal Antibody is meticulously manufactured under stringent quality control measures, guaranteeing batch-to-batch consistency and reproducibility. Each vial is rigorously tested to meet the highest standards of purity, ensuring optimal performance and reliability in every experiment.

In summary, the CYP2C8/9/18/19 Polyclonal Antibody is an indispensable tool for researchers seeking to unravel the intricate mechanisms of drug metabolism. Its exceptional specificity, sensitivity, and versatility make it an invaluable asset in various experimental settings. Trust in this cutting-edge antibody to advance your scientific endeavors and contribute to the advancement of pharmaceutical research and development.